Why Lead This Round
- First Mover Advantage: Position yourself as the strategic anchor in the $183B cardiovascular AI market before institutional competition intensifies
- Board Seat & Strategic Influence: Guaranteed board observer or full board seat with quarterly strategic planning participation
- Premium Valuation: Pre-money valuation of $15M provides exceptional entry point with 3-5x expected return at Series A
- De-risked Investment: MVP complete, 3 health system partnerships signed (18M lives), validated models (AUC >0.82), and clear 18-month path to FDA clearance
- Proven Leadership Team: Founders from Stanford Medicine, Mayo Clinic, and Google Health with 80+ years combined experience in cardiology and AI
- Massive Addressable Market: 659M people with CVD globally, $183B market by 2030, with AI in healthcare growing at 32% CAGR
Exclusive Lead Investor Terms
| Term | Benefit |
|---|---|
| Board Representation | Full board seat or board observer rights |
| Pro-Rata Rights | Guaranteed participation in all future rounds |
| Information Rights | Monthly financial reports, quarterly board meetings |
| Anti-Dilution | Weighted average anti-dilution protection |
| Co-Sale Rights | Tag-along rights on any founder sales |
| Advisory Role | Strategic input on clinical partnerships & FDA strategy |
| Liquidation Preference | 1.5x participating preferred (vs. 1x for other investors) |
Massive Market Opportunity
| Market Segment | 2024 Value | CAGR |
|---|---|---|
| Global CV Care Market | $146B | 3.8% |
| AI in Healthcare | $11B | 32% |
| Remote Patient Monitoring | $3.8B | 28% |
| AI Clinical Decision Support | $1.9B | 41% |
| Cardiovascular Diagnostics | $8.2B | 8.5% |
Our Technology Platform
⚡ Master Orchestrator - Central Coordination Engine
Intelligent task routing, load balancing, and real-time state management across all subsystems
📋 Task Routing
Queue management, priority sorting, subsystem selection
⚖️ Load Balancing
Agent distribution, resource allocation, throughput optimization
📊 State Management
Task lifecycle tracking, status monitoring, result aggregation
📡 Event Broadcasting
Real-time notifications, WebSocket events, alert distribution
🔧 Error Recovery
Automatic retry logic, fallback strategies, failure handling
📈 Metrics Collection
Performance monitoring, health checks, analytics tracking
🤖 7 Specialized AI Agents - Complete Cardiac Analysis
📈 ECG Agent
STEMI/NSTEMI detection, arrhythmia classification, ICD-10 coding
🫀 Echo Agent
HFrEF/HFpEF assessment, valve analysis, EF calculation
🧪 Lab Agent
Troponin & BNP analysis, lipid profiles, biomarker trends
⚠️ Risk Agent
TIMI/GRACE scoring, mortality risk, 10-year CVD prediction
🔍 Diagnostic Agent
Evidence synthesis, differential diagnosis, decision support
💊 Treatment Agent
Protocol generation, drug recommendations, dosage optimization
📊 Prognosis Agent
Outcome prediction, survival analysis, follow-up planning
📱 IoMT Platform - Real-Time Device Monitoring
24/7 continuous care with <1s alert latency across 4 protocols (MQTT, HTTP, CoAP, WebSocket)
📲 Device Registration
Device provisioning, credential generation, patient association
📡 Telemetry Processing
Real-time ingestion, stream processing, time-series storage
🚨 Alert Generation
Anomaly detection, threshold violations, alert prioritization
🔋 Device Monitoring
Connectivity tracking, battery status, heartbeat monitoring
🏥 PACS/DICOM Platform - Medical Imaging Analysis
6 specialized agents for comprehensive medical imaging with automated reporting
📥 DICOM Ingestion
C-STORE reception, C-FIND queries, metadata extraction
🖼️ Preprocessing
Image normalization, quality enhancement, artifact removal
✂️ Segmentation
4 parallel agents: cardiac chambers, vessel detection
📐 Quantification
Volume calculations, EF measurement, strain analysis
🔬 Specialized Analysis
T1/T2 mapping, calcium scoring, perfusion analysis
📄 Report Generation
DICOM SR creation, PDF export, HL7 integration
🎯 5 AI-Powered Risk Calculators
All models achieve C-statistic >0.75 with 95% confidence intervals, outperforming existing solutions by 15-20%
- 🫀 Acute Myocardial Infarction (AMI) C-stat ≥0.75
- 🧠 Stroke Risk (Ischemic, Hemorrhagic, TIA) C-stat ≥0.75
- 💔 Heart Failure (HFrEF & HFpEF) C-stat ≥0.75
- ⚡ Sudden Cardiac Death (ICD Guidance) C-stat ≥0.78
- 📈 Atrial Fibrillation (Highest Accuracy) C-stat ≥0.80
🔄 Complete Cardiac Workflow - 6-Step Integration
Financial Projections & Path to Profitability
| Metric | Year 1 | Year 2 | Year 3 |
|---|---|---|---|
| Monitored Patients | 50,000 | 250,000 | 1,000,000 |
| Revenue | $24M | $120M | $480M |
| Gross Margin | 75% | 82% | 85% |
| EBITDA | $12M | $24M | $168M |
Revenue Model: Per-member-per-month (PMPM) pricing at $40 for comprehensive cardiovascular care management
Average Contract Value: $480,000 annually per 1,000 members
18-Month Commercialization Roadmap
De-Risked Investment: Current Traction
Strategic Partnerships
- ✓ 3 Major Health Systems (MOUs signed, representing 18M covered lives)
- ✓ Leading Wearables Manufacturer (Partnership agreement for IoMT integration)
- ✓ Academic Medical Centers: Stanford Medicine, Weill Cornell Medicine, Harvard Medicine
- ✓ Advisory Board: 8 prominent cardiologists from top-tier institutions
Technical Milestones
- ✓ Platform MVP Complete and tested with pilot users
- ✓ Risk Models Validated (retrospective cohort of 50,000 patients, AUC >0.82)
- ✓ IoMT Integration with 12+ device types operational
- ✓ HIPAA Compliance and SOC 2 Type II certification achieved
- ✓ FDA Breakthrough Device Pathway eligibility confirmed
Sustainable Competitive Advantages
Be the Lead Investor Who Changes Cardiac Care Forever
Limited Time to Secure Lead Position
Apply for Lead Investor PositionContact for Lead Investor Discussions
Andrew Young
Director of Investment & Government Relations
yandrew@cardioailive.com+1 (919) 602-3105
Headquarters: Dublin, Ohio | San Francisco, California
This document contains confidential and proprietary information. Distribution is limited to qualified